PHARMACEUTICAL COMPOSITION

To provide medicinal use of a novel benzoazepine compound or a salt thereof having vasopressin V1a and V2 antagonism.SOLUTION: A pharmaceutical composition comprises a compound represented by the formula (1) or a salt thereof as an active ingredient. [In the formula, R1 represents optionally substit...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MATSUDA SATOSHI, MENJO YASUHIRO, HANARI YASUTAKA, TANAKA HIROTAKA, FUJITA SHIGEKAZU, TAKUWA MASAKUNI, URUSHIJIMA TATSUYA, FUJIWARA HIDETO, SUGA KEIZO, OTATSU KAZUHIRO, YAMABE HOKUTO
Format: Patent
Sprache:eng ; jpn
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To provide medicinal use of a novel benzoazepine compound or a salt thereof having vasopressin V1a and V2 antagonism.SOLUTION: A pharmaceutical composition comprises a compound represented by the formula (1) or a salt thereof as an active ingredient. [In the formula, R1 represents optionally substituted C1-6 alkyl or the like; L represents -C(=O)-NH- or the like; the ring A1 represents a hydrocarbon ring or the like; and the ring A2 represents a hydrocarbon ring or the like; where the rings A1 and A2 may each have at least one substituent.]SELECTED DRAWING: None 【課題】本発明は、バソプレシンV1a及びV2拮抗作用を有する新規なベンゾアゼピン化合物又はその塩の医薬用途を提供する。【解決手段】式(1)で表される化合物またはその塩を有効成分とする医薬組成物[式中、R1は、置換されていてもよいC1−6アルキル等を示す;Lは、−C(=O)−NH−等を示す;環A1は、炭化水素環等を示す;環A2は、炭化水素環等を示す;環A1及びA2はそれぞれ、少なくとも1個の置換基を有していてもよい。]。【選択図】なし